By Rick Nauert PhD Senior News Editor
Reviewed by John M. Grohol, Psy.D.on April 22, 2011
New research shows that antidepressant medication often does not resolve all of the symptoms associated with depression.
Investigators discovered that even in the best case, that is when an individual shows a distinct improvement after beginning medication, symptoms such as insomnia, sadness and decreased concentration are likely to persist.
“Widely used antidepressant medications, while working overall, missed these symptoms. If patients have persistent residual symptoms, these individuals have a high probability of incomplete recovery,” said Shawn McClintock, Ph.D., of University of Texas Southwestern medical school.
Investigators studied a wide range of symptoms of depression — including sadness, suicidal thoughts, and changes in sleep patterns, appetite/weight, concentration, outlook and energy/fatigue — at the start of the trial and at the end of the antidepressant treatment course.
Integral to the investigation was the use of data from the Sequenced Treatment Alternatives to Relieve Depression, or STAR*D study, the largest ever on the treatment of major depressive disorder and considered a benchmark in the field of depression research. The six-year, National Institute of Mental Health-sponsored study initially included more than 4,000 patients with major depressive disorder from clinics across the country.
All responders reported between three to 13 residual depressive symptoms, and 75 percent of participants reported five symptoms or more. Some of their symptoms included insomnia that occurs in the middle of the night (nearly 79 percent); sadness (nearly 71 percent); and decreased concentration and decision-making skills (nearly 70 percent).
Thoughts of suicide rarely persisted or emerged during treatment, researchers found.
“Some people fear that antidepressant medication increases thoughts of suicide,” McClintock said. “This provided counterevidence of that.”
Researchers discovered that depression medication such as SSRIs, or selective serotonin reuptake inhibitor, enabled only 33 percent of participants to resolve depression symptoms (go into remission) in the first three months of the study.
Fifteen precent of participants did not respond to the medication — with response defined as a 50 precent decrease in severity of depression. The average age of participants was 40, 73 percent were white, and 66 percent were female.
McClintock believes the research demonstrates the need to develop more targeted antidepressant therapies to decrease depressive symptoms, and to understand better the association between depression and concentration.
The study highlights the fact that while medication can assist recovery from depression, residual depressive symptoms need attention to help individuals return to normal and maintain in the long run.
The paper discussing the research findings is available in the April print issue of the Journal of Clinical Psychopharmacology.
Source: University of Texas Southwestern Medical School
Related News Articles
-->Related Clinical Articles
-->
Anxiety, Depression, Featured, General, Health-related, LifeHelper, Medications, Mental Health and Wellness, Professional, Psychology, Psychotherapy, Research, Sleep, Stress, Suicide -->
DrugsDrug Index Intro to Psychiatric MedsQuestions to Ask Your DoctorMedication SafetyDiscount Pharmacy and Patient Assistance ProgramsLower Your Drug CostsTop 25 Psychiatric Meds of 2009 New Depression Medications on the Horizon Medications and ChildrenMedications and SeniorsMedications While Pregnant Connect with OthersAsk a Drug Question From Our News BureauHappiest Places to Live May Be Bad News for Suicidal Alleviating Surgical Anxiety and Pain in Children Prenatal Exposure to Pesticide Linked to Lower IQ
Just Published...Saving ALL The StarfishHAPPY 1 Year Anniversary Mental Health Humor Blogging at... Willpower, Self-Control Can Be LearnedThe Hadza Zen
What's Hot7 Factors that Predict Positive AgingadvertisementMost Popular NewsHappiest Places to Live May Be Bad News for Suicidal Alleviating Surgical Anxiety and Pain in Children Prenatal Exposure to Pesticide Linked to Lower IQ Conflicting Evidence on Impact of Video Game Violence Regulating Brain Waves by Mindfulness Meditation Impacts Pain, Memory Supportive Environment Cuts Suicide Attempts by Gay Teens Gender Discrimination in the Workplace The Science Behind Falling in Love Extreme Gullibility a Warning Sign of Dementia Most Popular Blog PostsWillpower, Self-Control Can Be Learned Analyzing the Thinking Process: Interview with Diane Halpern Recovery From Addiction and Depression: An Interview with Vivian Eisenecher 9 Steps to Better Communication Today What is Anxiety? Catherine Zeta Jones: Bipolar II Is Not Diet Coke How to Spot a Narcissist How Long For Good Sex? 5 Minutes Will Do 5 Tips for Dealing with Guilt Friends with Benefits Subscribe to Our Weekly Newsletter
advertisement
Find a Therapist
Users Online: 3528
Join Us Now!
Local GuidesAll Guides
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
DC
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
#footer { height:220px; } #foot-mid { margin:0 0 0 40px; } Home About Us Advertise with Us Contact Us
Privacy Policy Terms of Use Site Map Disclaimer/Disclosure Feeds
Site last updated: 24 Apr 2011 Psych Central Professional
Psych Central Answers
Psych Central Blog Network
Psych Central News
Tests & Quizzes
Sanity Score
Forums NeuroTalk
ADHD
Anxiety
Bipolar
Depression
Schizophrenia
Psychotherapy
with the
HONcode
standard:
Verify here
0 comments:
Post a Comment